(Q51950827)

18 April 2018

title

Are patients with pituitary adenomas at an increased risk of mental disorders? (English)

1 reference

18 April 2018

author

Hans-Ulrich Wittchen

2

1 reference

18 April 2018

author name string

Korali Z

1

1 reference

18 April 2018

Pfister H

3

1 reference

18 April 2018

Höfler M

4

1 reference

18 April 2018

Oefelein W

5

1 reference

18 April 2018

Stalla GK

6

1 reference

18 April 2018

language of work or name

English

0 references

publication date

1 January 2003

1 reference

18 April 2018

Acta Psychiatrica Scandinavica

published in

1 reference

18 April 2018

volume

107

1 reference

18 April 2018

issue

1

1 reference

18 April 2018

page(s)

60-68

1 reference

18 April 2018

The quality of life of adults with growth hormone deficiency: comparison with diabetic patients and control subjects.

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02383.X

An account of the quality of life of patients after treatment for non-functioning pituitary tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02383.X

Cognitive dysfunction in patients with pituitary tumour who have been treated with transfrontal or transsphenoidal surgery or medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02383.X

Cognitive dysfunction in patients treated for pituitary tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02383.X

Diagnostic categorization of psychiatric disturbance in Cushing's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02383.X

A prospective study of psychiatric and psychological aspects of Cushing's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02383.X

The longitudinal course of psychopathology in Cushing's syndrome after correction of hypercortisolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02383.X

Neuropsychiatric manifestations of patients with Cushing's syndrome. Relationship to cortisol and adrenocorticotropic hormone levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02383.X

Clinical correlates of major depression in Cushing's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02383.X

Effect of chronic bromocriptine treatment on psychological profile of patients with PRL-secreting pituitary adenomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02383.X

Emotional aspects of hyperprolactinemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02383.X

Reliability and validity studies of the WHO--Composite International Diagnostic Interview (CIDI): a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02383.X

Reliability and clinical validity of UM-CIDI DSM-III-R generalized anxiety disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02383.X

Prevalence and 12-month outcome of threshold and subthreshold mental disorders in primary care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02383.X

Affective disorders and endocrine disease. New insights from psychosomatic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02383.X

Psychiatric aspects of Cushing's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02383.X

21 January 2018

Hormones and behaviour

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02383.X

7 January 2021

Decreased psychological well-being in adult patients with growth hormone deficiency.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02383.X

7 January 2021

Quality of life assessment before and after growth hormone treatment in adults with growth hormone deficiency

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02383.X

7 January 2021

Psychosomatic view of endocrine disorders

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02383.X

7 January 2021

Living with acromegaly

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02383.X

7 January 2021

Psychiatric morbidity in acromegaly.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02383.X

7 January 2021

Hyperprolactinaemia as a result of immaturity or regression: the concept of maternal subroutine. A new model of psychoendocrine interactions

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02383.X

7 January 2021

Psychological correlates of hyperprolactinemia in males.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02383.X

7 January 2021

Lifetime and six-month prevalence of mental disorders in the Munich Follow-Up Study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02383.X

7 January 2021

Reliability and procedural validity of UM-CIDI DSM-III-R phobic disorders

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.02383.X

7 January 2021

10.1034/J.1600-0447.2003.02383.X

Identifiers

DOI

1 reference

18 April 2018

1 reference

18 April 2018